Parvus Therapeutics Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Altimmune Targets Upstream A

When Roche goes hunting for assets and partnerships in the immunology space, it does so with an eye toward novelty and versatility. The big pharma believes it is well suited to leveraging promising

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Parvus, Genentech Collaborat